BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 21776018)

  • 21. Involvement of both tumor necrosis factor-alpha-induced necrosis and p53-mediated caspase-dependent apoptosis in nephrotoxicity of cisplatin.
    Yano T; Itoh Y; Matsuo M; Kawashiri T; Egashira N; Oishi R
    Apoptosis; 2007 Oct; 12(10):1901-9. PubMed ID: 17701360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral Administration of Caffeine Exacerbates Cisplatin-Induced Hearing Loss.
    Sheth S; Sheehan K; Dhukhwa A; Al Aameri RFH; Mamillapalli C; Mukherjea D; Rybak LP; Ramkumar V
    Sci Rep; 2019 Jul; 9(1):9571. PubMed ID: 31267026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting nitrative stress for attenuating cisplatin-induced downregulation of cochlear LIM domain only 4 and ototoxicity.
    Jamesdaniel S; Rathinam R; Neumann WL
    Redox Biol; 2016 Dec; 10():257-265. PubMed ID: 27821327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epicatechin protects the auditory organ by attenuating cisplatin-induced ototoxicity through inhibition of ERK.
    Lee JS; Kang SU; Hwang HS; Pyun JH; Choung YH; Kim CH
    Toxicol Lett; 2010 Dec; 199(3):308-16. PubMed ID: 20883750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha-lipoic acid protects against cisplatin-induced ototoxicity via the regulation of MAPKs and proinflammatory cytokines.
    Kim J; Cho HJ; Sagong B; Kim SJ; Lee JT; So HS; Lee IK; Kim UK; Lee KY; Choo YS
    Biochem Biophys Res Commun; 2014 Jun; 449(2):183-9. PubMed ID: 24796665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cisplatin ototoxicity involves cytokines and STAT6 signaling network.
    Kim HJ; Oh GS; Lee JH; Lyu AR; Ji HM; Lee SH; Song J; Park SJ; You YO; Sul JD; Park C; Chung SY; Moon SK; Lim DJ; So HS; Park R
    Cell Res; 2011 Jun; 21(6):944-56. PubMed ID: 21321603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphorylation of eIF2α suppresses cisplatin-induced p53 activation and apoptosis by attenuating oxidative stress via ATF4-mediated HO-1 expression in human renal proximal tubular cells.
    Ju SM; Jo YS; Jeon YM; Pae HO; Kang DG; Lee HS; Bae JS; Jeon BH
    Int J Mol Med; 2017 Dec; 40(6):1957-1964. PubMed ID: 29039478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of cisplatin-induced ototoxicity and prevention.
    Rybak LP; Whitworth CA; Mukherjea D; Ramkumar V
    Hear Res; 2007 Apr; 226(1-2):157-67. PubMed ID: 17113254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective roles of fenofibrate against cisplatin-induced ototoxicity by the rescue of peroxisomal and mitochondrial dysfunction.
    Kim SJ; Park C; Lee JN; Park R
    Toxicol Appl Pharmacol; 2018 Aug; 353():43-54. PubMed ID: 29908243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction of acute cisplatin ototoxicity and nephrotoxicity in rats by oral administration of allopurinol and ebselen.
    Lynch ED; Gu R; Pierce C; Kil J
    Hear Res; 2005 Mar; 201(1-2):81-9. PubMed ID: 15721563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of STAT1/IRF-1 on synergistic ROS production and loss of mitochondrial transmembrane potential during hepatic cell death induced by LPS/d-GalN.
    Lee HJ; Oh YK; Rhee M; Lim JY; Hwang JY; Park YS; Kwon Y; Choi KH; Jo I; Park SI; Gao B; Kim WH
    J Mol Biol; 2007 Jun; 369(4):967-84. PubMed ID: 17475277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AMP-activated protein kinase contributes to ROS-mediated p53 activation in cisplatin-induced nephrotoxicity.
    Ju SM; Bae JS; Jeon BH
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(21):6691-6700. PubMed ID: 34787874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cisplatin-induced ototoxicity: Updates on molecular mechanisms and otoprotective strategies.
    Tang Q; Wang X; Jin H; Mi Y; Liu L; Dong M; Chen Y; Zou Z
    Eur J Pharm Biopharm; 2021 Jun; 163():60-71. PubMed ID: 33775853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dunnione ameliorates cisplatin ototoxicity through modulation of NAD(+) metabolism.
    Kim HJ; Pandit A; Oh GS; Shen A; Lee SB; Khadka D; Lee S; Shim H; Yang SH; Cho EY; Kwak TH; Choe SK; Park R; So HS
    Hear Res; 2016 Mar; 333():235-246. PubMed ID: 26341473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cisplatin-induced hair cell death requires STAT1 and is attenuated by epigallocatechin gallate.
    Schmitt NC; Rubel EW; Nathanson NM
    J Neurosci; 2009 Mar; 29(12):3843-51. PubMed ID: 19321781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dexamethasone Protects Against Apoptotic Cell Death of Cisplatin-exposed Auditory Hair Cells In Vitro.
    Dinh CT; Chen S; Bas E; Dinh J; Goncalves S; Telischi F; Angeli S; Eshraghi AA; Van De Water T
    Otol Neurotol; 2015 Sep; 36(9):1566-71. PubMed ID: 26375980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of reactive oxygen species in p53 activation during cisplatin-induced apoptosis of rat mesangial cells.
    Ju SM; Pae HO; Kim WS; Kang DG; Lee HS; Jeon BH
    Eur Rev Med Pharmacol Sci; 2014; 18(8):1135-41. PubMed ID: 24817286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of cisplatin ototoxicity: theoretical review.
    Gonçalves MS; Silveira AF; Teixeira AR; Hyppolito MA
    J Laryngol Otol; 2013 Jun; 127(6):536-41. PubMed ID: 23651576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levosimendan ameliorates cisplatin-induced ototoxicity: Rat model.
    Gozeler MS; Ekinci Akdemir FN; Yildirim S; Sahin A; Eser G; Askin S
    Int J Pediatr Otorhinolaryngol; 2019 Jul; 122():70-75. PubMed ID: 30978472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allicin protects auditory hair cells and spiral ganglion neurons from cisplatin - Induced apoptosis.
    Wu X; Li X; Song Y; Li H; Bai X; Liu W; Han Y; Xu L; Li J; Zhang D; Wang H; Fan Z
    Neuropharmacology; 2017 Apr; 116():429-440. PubMed ID: 28062185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.